Veterinary Orthopedic Medicine Market Showing Strong Demand Growth from 2026–2030

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Autologous Stem Cell And Non-Stem Cell Based Therapies Market Expected To Change Between 2026 And 2030?

The veterinary orthopedic medicine market has experienced significant growth in recent years. Its valuation is anticipated to rise from $4.03 billion in 2025 to $4.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.1%. This historical surge was influenced by factors such as the high incidence of osteoarthritis and joint disorders, an expanding companion animal population, the initial limited accessibility to advanced orthopedic treatments, a rise in equine and canine sports activities, and the broadening reach of veterinary hospitals and clinics.

The veterinary orthopedic medicine market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $5.99 billion in 2030, demonstrating an 8.0% compound annual growth rate (CAGR). This projected growth can be ascribed to several factors, including developments in PRP and stem cell therapies, the greater application of viscosupplements and NSAIDs, the adoption of sophisticated surgical methods, increased funding in veterinary orthopedic studies, and heightened understanding regarding animal mobility and overall well-being. Key dynamics expected during this forecast timeframe encompass a rise in musculoskeletal conditions among animals, the increasing uptake of minimally invasive orthopedic procedures, an expansion in stem cell and biologics-based therapies, the broadening of veterinary rehabilitation and physiotherapy provisions, and a focus on managing pain and facilitating post-operative recovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15955&type=smp

What Underlying Factors Are Accelerating The Growth Of The Autologous Stem Cell And Non-Stem Cell Based Therapies Market?

The escalating occurrence of pet orthopedic conditions is projected to stimulate the growth of the veterinary orthopedic medicine market moving forward. Pet orthopedic diseases are defined as ailments affecting the musculoskeletal system of companion animals, particularly dogs and cats. The rising prevalence of these conditions can be attributed to elements such as breed-specific tendencies, an increase in obesity levels, and environmental factors like inadequate exercise and substandard nutrition. Veterinary orthopedic medicine plays an essential part in diagnosing, managing, and treating orthopedic disorders in pets, thereby helping to alleviate pain, restore mobility, and improve their general quality of life. For example, in July 2024, a report from the Morris Animal Foundation, a US-based non-profit organization, indicated that over 14 million adult dogs in the United States were afflicted with osteoarthritis. Additionally, available data points out that around 90% of cats over the age of 12 display radiographic indications of osteoarthritis, highlighting the substantial prevalence of this ailment in aging pets and underscoring a mounting need for greater understanding and advancements in treatment options. Thus, the increasing incidence of pet orthopedic diseases is a key driver for the expansion of the veterinary orthopedic medicine market.

How Is The Autologous Stem Cell And Non-Stem Cell Based Therapies Market Structured Across Different Segments?

The veterinary orthopedic medicine market covered in this report is segmented –

1) By Product: Biologics, Viscosupplements, Pharmaceuticals

2) By Animal Type: Canine, Feline, Equine, Cattle, Swine, Other Animal Types

3) By Application: Osteoarthritis, Degenerative Joint Disease, Joint Inflammation Or Pain, Other Applications

4) By End-use: Veterinary Hospitals, Veterinary Clinics, Other End Users

Subsegments:

1) By Biologics: Platelet-Rich Plasma (PRP), Stem Cell Therapy, Bone Marrow Aspirate Concentrate (BMAC), Viscosupplements

2) By Viscosupplements: Hyaluronic Acid, Corticosteroid Injections

3) By Pharmaceuticals: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Antibiotics

Which Trends Are Shaping The Future Of The Veterinary Orthopedic Medicine Market?

Leading companies in veterinary orthopedic medicine are concentrating their efforts on investing in advanced technologies, including 3D printing labs for creating custom implants, regenerative therapies like stem cell and platelet-rich plasma (PRP) treatments, and sophisticated imaging techniques such as MRI and CT scans designed for animal patients. A 3D Printing Lab for Pet Orthopedic Surgeries is a specialized center that employs 3D printing technology to produce custom implants, prosthetics, and surgical instruments specifically for veterinary orthopedic procedures. For instance, in October 2024, VCA Animal Hospitals, a U.S.-based provider of high-quality veterinary care for pets, launched a 3D printing lab at its VCA Northwest Veterinary Specialists facility in Clackamas, Oregon. This lab, which utilizes advanced 3D printing technology, aims to improve orthopedic surgeries for pets by developing custom implants and surgical guides tailored to each pet’s unique anatomy. Osteoarthritis, affecting 20% of dogs older than one year and 80% of those over eight, frequently requires surgical intervention. With this personalized strategy, VCA endeavors to facilitate faster recovery times and enhanced surgical outcomes, managing complex orthopedic conditions more effectively than traditional methods.

Which Major Players Dominate The Autologous Stem Cell And Non-Stem Cell Based Therapies Market?

Major companies operating in the veterinary orthopedic medicine market are Zoetis Inc., Elanco Animal Health, Merck Animal Health, Virbac SA, Ceva Santé Animale, Vetoquinol S.A., Bimeda U.S., American Regent, Hyalogic LLC, BioMedtrix LLC, IMEX Veterinary Inc., Orthomed (UK) Ltd, Veterinary Orthopedic Implants, Integra LifeSciences, Avante Animal Health, DePuy Synthes Vet, KYON AG, Securos Surgical, Arthrex Vet Systems, INNOPLANT Medizintechnik GmbH, VetWelding AG, Scil Animal Care, Intrauma S.p.A., Aysam Veterinary Orthopedics

Read the full veterinary orthopedic medicine market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report

Which Region Is Projected To Dominate The Autologous Stem Cell And Non-Stem Cell Based Therapies Market During The Forecast Period?

North America was the largest region in the veterinary orthopedic medicine market in 2025. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autologous Stem Cell And Non-Stem Cell Based Therapies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15955&type=smp

Browse Through More Reports Similar to the Global Veterinary Orthopedic Medicine Market 2026, By The Business Research Company

Veterinary Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report

Veterinary Healthcare Market 2026

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-market

Veterinary Medical Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795